After more than 20 years on the market, the established traditional Chinese medicine company Tianshi Li (600535.SH) is on the verge of a transformation, shifting from a privately-owned enterprise to a...
In a meeting in July 2022, Kuaishou CEO Cheng Yixiao asked the executive in charge of commercialization: Why is it that Kuaishou's user base is half that of Douyin, yet its commercial revenue is only ...